Seeing Is Believing
Currently out of the existing stock ratings of Edward Tenthoff, 671 are a BUY (90.07%), 62 are a HOLD (8.32%), 12 are a SELL (1.61%).
Analyst Edward Tenthoff, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 44.69% that have a potential upside of 54.16% achieved within 279 days.
Edward Tenthoff’s has documented 1,479 price targets and ratings displayed on 77 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FULC, Fulcrum Therapeutics at 29-May-2025.
Analyst best performing recommendations are on MIST (MILESTONE PHARMACEUTICALS).
The best stock recommendation documented was for MIST (MILESTONE PHARMACEUTICALS) at 3/23/2020. The price target of $3 was fulfilled within 1 day with a profit of $11 (78.57%) receiving and performance score of 785.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$12
$-15.6 (-56.52%)
1 years 7 months 10 days ago
(13-Nov-2023)
2/2 (100%)
$1.82 (17.88%)
14
Buy
$23
$-4.6 (-16.67%)
$22.5
1 years 9 months 12 days ago
(11-Sep-2023)
2/2 (100%)
$8.95 (63.70%)
141
Hold
$25
$-2.6 (-9.42%)
2 years 3 months 20 days ago
(03-Mar-2023)
1/3 (33.33%)
$15.15 (153.81%)
325
Hold
$25
2 years 7 months 27 days ago
(27-Oct-2022)
1/4 (25%)
$6.75 (36.99%)
151
Buy
$11
3 years 21 days ago
(03-Jun-2022)
2/2 (100%)
$3.33 (40.64%)
1025
Which stock is Edward Tenthoff is most bullish on?
Which stock is Edward Tenthoff is most reserved on?
What Year was the first public recommendation made by Edward Tenthoff?